Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

NCT03813134 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

428

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock

Interventions

PROCEDURE: Percutaneous coronary intervention (PCI)
OTHER: Pharmacological Support
DEVICE: VA-ECMO

Sponsor

University of Leicester

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]